Radium-223, An Alpha Emitter Treatment for Advanced Prostate Cancer Called A Breakthrough Treatment

In an interview about radium 223 with Medscape Medical News, Dr. Vapiwala pointed out that radium-223 is the first alpha-emitter to reach the market, and described it as a "breakthrough for radiopharmaceuticals" and "another breakthrough for prostate cancer," as it joins several other agents that have recently been approved for this disease. She characterized the [...]

Bayer Healthcare and Algeta Disappoint & Let Men with Advanced Prostate Cancer Down

The committee to start the early access clinical trials for drugs and treatments for men with advanced prostate cancer has been very hard at work. Based on the leadership and tenacity of Jan Manarite of the Prostate Cancer Research Institute (PCRI) we have managed to encourage, beg and cajole a number of pharmaceutical (pharma) companies [...]

By |2013-04-23T17:37:07-04:00April 23rd, 2013|